The Perils of PNH – Recognition, Treatment & Thrombotic Implications, Dr. Christopher Patriquin (11/14/23)-Webinar Case

Speaker: Christopher Patriquin MD MSc FRCPC
Hematology & Apheresis Medicine, University Health Network
Assistant Professor of Medicine, University of Toronto

Learning Objectives

• Review the differential diagnosis of hemolytic anemias
• Discuss the recognition, diagnosis, and general management of paroxysmal nocturnal hemoglobinuria (PNH)
• Understand the pathophysiology, risk, and treatment of PNH-associated thromboembolism
• Explore novel therapies for PNH and their implications

Accreditation: This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours. Certificates of Attendance will be sent to all CHS members who participate.

This webinar is supported by a grant from Alexion and the CHS Scientific Planning Committee has planned it to achieve scientific integrity, objectivity and balance.

Scientific Planning Committee

Dr. Pallavi Ganguli – Resident Physician, Hematology
Danyal Ladha – Resident Physician, Hematology
Dr. Joanne Britto – Clinical Fellow, Malignant Hematology (Lymphoproliferative Disorders)
Dr. Yan Xu – Fellow Physician, Hematology/Thrombosis
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician,
Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre

Conflict of Interest: SPC None

Conflict of Interest-Presenter:

• Speaking and advisory board honoraria: Alexion and SOBI
• Advisory board honoraria: Apellis; BioCryst; Novartis; Roche; Sanofi; Takeda